Related Experiment Video
Updated: May 20, 2026
07:36
Analyzing Tumor and Tissue Distribution of Target Antigen Specific Therapeutic Antibody
Published on: May 16, 2020
Recent progress in cancer therapy with radiolabeled monoclonal antibodies
Therapeutic Delivery
|July 24, 2012
Abstract:
"Progress in the use of RAIT for cancer therapy has been slow but steady, involving the reengineerin1g of antibodies (reducing murine component, altering size and clearance properties), and pretargeting methods for improvving tumor:blood and tumor:organ ratios are continuing to evolve".
Insights
Radioimmunotherapy (RAIT) for cancer treatment is advancing steadily. Innovations in antibody engineering and pretargeting strategies are improving tumor targeting and therapeutic efficacy.
Area of Science:
- Oncology and Immunology
- Radiopharmaceutical Therapy
Background:
- Radioimmunotherapy (RAIT) involves using antibodies to deliver radiation directly to cancer cells.
- Progress in RAIT has been incremental, focusing on overcoming previous limitations.
Discussion:
- Antibody engineering efforts aim to reduce immunogenicity (e.g., humanization) and optimize pharmacokinetic properties (size, clearance).
- Pretargeting strategies are being developed to enhance tumor-to-blood and tumor-to-organ ratios, improving therapeutic index.
Key Insights:
- Continuous refinement of antibody components is crucial for effective RAIT.
- Advanced pretargeting techniques are essential for maximizing radiation dose to tumors while minimizing off-target effects.
Outlook:
- Further development in antibody design and pretargeting holds promise for more effective cancer treatments.
- The evolution of RAIT is expected to lead to improved outcomes in targeted cancer therapy.
More Related Videos
Related Concept Videos
02:57Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
01:27Tumor Immunotherapy
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.